China Pharma (CPHI)
Create an Alert
0.235
+0.01 +3.07%
AMEX
Jun 17, 8:00PM
BATS Real time
Currency in USD
China Pharma Revenue Quarterly:
8.249M for March 31, 2013China Pharma Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 8.249M |
| Dec. 31, 2012 | 11.65M |
| Sept. 30, 2012 | 12.18M |
| June 30, 2012 | 14.60M |
| March 31, 2012 | 16.09M |
| Dec. 31, 2011 | 22.46M |
| Sept. 30, 2011 | 20.99M |
| June 30, 2011 | 19.60M |
| March 31, 2011 | 18.12M |
| Dec. 31, 2010 | 23.97M |
| Sept. 30, 2010 | 18.68M |
| June 30, 2010 | 16.63M |
| March 31, 2010 | 15.10M |
| Dec. 31, 2009 | 19.58M |
| Sept. 30, 2009 | 15.52M |
| June 30, 2009 | 13.60M |
| March 31, 2009 | 12.99M |
| Dec. 31, 2008 | 15.36M |
| Sept. 30, 2008 | 12.61M |
| June 30, 2008 | 11.28M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
CPHI Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 5.378B |
| Daiichi Sankyo | 3.022B |
| Astellas Pharma | 3.218B |
CPHI Revenue Quarterly Rankings
| Overall |
62nd percentile 6240 of 16773 |
| Sector |
69th percentile 436 of 1408 in Healthcare |
| Industry |
68th percentile 42 of 135 in Drug Manufacturers - Major |
CPHI Revenue Quarterly Range, Past 5 Years
| Minimum | 8.249M | Mar 2013 |
| Maximum | 23.97M | Dec 2010 |
| Average | 15.96M |
CPHI News
China Pharma Holdings' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 15
Seeking Alpha May 15
China Pharma Holdings' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha Mar 15
Seeking Alpha Mar 15